To promote ketone metabolism, medium-chain triglyceride (MCT) oil and a ketogenic diet could be introduced as an alternative source of energy in the brain of AD patients.
MCT Oil
Cognition, memory, and focus is the main area connected here, and any felt benefit should be read together with the human evidence base.
Representative tier calculated from paper evidence that passed the collection audit.
Main benefit evidence
The representative ingredient tier is calculated from these target-level evidence groups.
Cognition and focus2 studiesTier-BCognition, memory, and focusFairly consistent positive signal in studiesFelt benefit focusSupplement contextPotential benefit studied in Cognition and focus.Open metrics>
Condition-specific evidence2 studiesTier-CCondition-specific health context in a specific contextFairly consistent positive signal in studiesResearch marker focusSupplement contextThis result was studied for Condition-specific health context in a narrower population or condition-specific context. It should not be generalized as an everyday supplement effect.Closer to a research marker than a directly felt benefit.Open metrics>
Glucose and metabolic health1 studiesTier-CGlucose and metabolic health markersSome positive signal observedResearch marker focusPatient-group studyThis card is closer to a measured biomarker or lab outcome than a directly felt user benefit.Closer to a research marker than a directly felt benefit.Open metrics>
Nutrient status1 studiesTier-CNutrient status markersSome positive signal observedResearch marker focusSupplement contextThis card is closer to a measured biomarker or lab outcome than a directly felt user benefit.Closer to a research marker than a directly felt benefit.Open metrics>
Exercise performance and recovery2 studiesTier-CExercise performance and recoverySome positive signal observedFelt benefit focusPatient-group studyPotential benefit studied in Exercise performance and recovery.Open metrics>
Immune and respiratory health1 studiesTier-CImmune and respiratory supportSome positive signal observedFelt benefit focusPatient-group studyPotential benefit studied in Immune and respiratory health.Open metrics>
Recent research
10 new papers were added in this period. No new risk signal was identified.
What's new
Most notable recent finding
Study dosage range (reference only)
Key cautions to review
Standalone side-effect signals and combination cautions are listed separately.
Standalone side effects
Evidence summaries
Paper IDs and full lists are private. Only study types and summaries are shown.
[Abstract]: Background Impaired brain glucose metabolism appears to be a potential pathogenic feature of mild cognitive impairment (MCI). This study examined the potential for increasing circulating ketone bodies through medium chain triglyceride (MCT) supplem
It is proposed that MCT may expand the usable energy supply, particularly in the form of ketone bodies, and improve the oxidative capacity of the heart in this population of people with carnitine palmitoyltransferase 2 deficiencies.
3 more summariesLimited representative sample by study type.>
MCTs (6 g/d) could increase the muscle strength and function of frail elderly individuals and also improve their ADL.
This work shows how interfacial crystallization dynamics and mechanical strength can be linked to the molecular structure and crystallization behavior of glyceride crystals.
[Abstract]: BACKGROUND Supplementation with medium-chain triglycerides (MCTs) was previously shown to increase muscle function in frail elderly individuals. OBJECTIVE We aimed to assess effects of MCTs on cognition in such individuals. METHODS We enrolled 64 e